Omnix Medical

About:

Omnix Medical develope and commercialize highly effective antibiotic agents against resistant pathogenic bacterial strains.

Website: http://www.omnixmedical.com/

Top Investors: European Innovation Council, National Institutes of Health, Tal Ventures, Entrée Capital, VLX Ventures

Description:

Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains. Omnix is addressing an enormous and rapidly growing threat to public health, represented by millions worldwide, who suffer from infections associated with resistant bacteria. Omnix’s technology will tilt the odds in the battle against resistant bacteria and improve the lives of many people worldwide.

Total Funding Amount:

$14M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Jerusalem, Yerushalayim, Israel

Founded Date:

2015-01-01

Contact Email:

contact(AT)omnixmedical.com

Founders:

Moshik Cohen-Kutner, Niv Bachnoff, Rom Lakritz

Number of Employees:

11-50

Last Funding Date:

2022-04-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai